165 related articles for article (PubMed ID: 27580518)
41. Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.
Kirov II; Liu S; Fleysher R; Fleysher L; Babb JS; Herbert J; Gonen O
Radiology; 2010 Mar; 254(3):858-66. PubMed ID: 20177098
[TBL] [Abstract][Full Text] [Related]
42. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
[TBL] [Abstract][Full Text] [Related]
43. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
[TBL] [Abstract][Full Text] [Related]
44. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
45. Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.
White TL; Monnig MA; Walsh EG; Nitenson AZ; Harris AD; Cohen RA; Porges EC; Woods AJ; Lamb DG; Boyd CA; Fekir S
Neuropsychopharmacology; 2018 Jun; 43(7):1498-1509. PubMed ID: 29511334
[TBL] [Abstract][Full Text] [Related]
46. 1H MR spectroscopy of mesial temporal lobe epilepsies treated with Gamma knife.
Hájek M; Dezortová M; Liscák R; Vymazal J; Vladyka V
Eur Radiol; 2003 May; 13(5):994-1000. PubMed ID: 12695820
[TBL] [Abstract][Full Text] [Related]
47. Altered neurometabolism in major depressive disorder: A whole brain
Kahl KG; Atalay S; Maudsley AA; Sheriff S; Cummings A; Frieling H; Schmitz B; Lanfermann H; Ding XQ
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109916. PubMed ID: 32169561
[TBL] [Abstract][Full Text] [Related]
48. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
49. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.
Savic I; Thomas AM; Ke Y; Curran J; Fried I; Engel J
Acta Neurol Scand; 2000 Sep; 102(3):179-88. PubMed ID: 10987378
[TBL] [Abstract][Full Text] [Related]
50. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
51. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
Shutter L; Tong KA; Holshouser BA
J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
[TBL] [Abstract][Full Text] [Related]
52. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
[TBL] [Abstract][Full Text] [Related]
53. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
54. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
[TBL] [Abstract][Full Text] [Related]
55. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
56. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
[TBL] [Abstract][Full Text] [Related]
57. Non-invasive measurement of biochemical profiles in the healthy fetal brain.
Pradhan S; Kapse K; Jacobs M; Niforatos-Andescavage N; Quistorff JL; Lopez C; Bannantine KL; Andersen NR; Vezina G; Limperopoulos C
Neuroimage; 2020 Oct; 219():117016. PubMed ID: 32526384
[TBL] [Abstract][Full Text] [Related]
58. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
[TBL] [Abstract][Full Text] [Related]
59. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.
Träber F; Block W; Freymann N; Gür O; Kucinski T; Hammen T; Ende G; Pilatus U; Hampel H; Schild HH; Heun R; Jessen F
Eur Radiol; 2006 May; 16(5):1096-103. PubMed ID: 16416279
[TBL] [Abstract][Full Text] [Related]
60. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
Angelie E; Bonmartin A; Boudraa A; Gonnaud PM; Mallet JJ; Sappey-Marinier D
AJNR Am J Neuroradiol; 2001 Jan; 22(1):119-27. PubMed ID: 11158897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
